Dow Down 1.40% Nasdaq Down 1.59%

Inovio Pharmaceuticals, Inc. (INO)

-NasdaqGS
9.80 Down 0.05(0.51%) Oct 1, 4:00PM EDT
|After Hours : 10.08 Up 0.28 (2.86%) Oct 1, 7:58PM EDT
Prev Close:9.85
Open:10.33
Bid:9.80 x 3200
Ask:10.24 x 400
1y Target Est:21.00
Beta:3.39
Next Earnings Date:N/A
Day's Range:9.65 - 10.45
52wk Range:6.52 - 15.80
Volume:1,487,104
Avg Vol (3m):1,355,580
Market Cap:591.90M
P/E (ttm):N/A
EPS (ttm):N/A
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Related Video

Comparison

Symbol% ChgMkt Cap
INODown 0.51%591.90M
AZNDown 1.27%89.08B
PFEDown 1.42%184.84B
SNYDown 0.97%146.64B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):34.22
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.70
Quarterly EPS Est (Sep-14) :-0.14
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Inovio Pharmaceuticals, Inc., together with its subsidiaries, discovers, develops, and develops synthetic vaccines and immune therapies focusing on cancers and infectious diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback